Similar articles

• [Nuclear medicine in oncology: new diagnostic and therapeutic methods].

  Maublant J, Lumbroso J, Cachin F, Raoul JL, Syrota A, Vuillez JP. Maublant J, et al. Bull Cancer. 2001 Jan;88(1):35-44. Bull Cancer. 2001. PMID: 11182651 Review. French. No abstract available.
• FDG-PET in clinical oncology: review of the literature and report of one institution's experience.

  Oehr P, Ruhlmann J, Biersack HJ. Oehr P, et al. J Investig Med. 1999 Nov;47(9):452-61. J Investig Med. 1999. PMID: 10572375 Review. No abstract available.
• Oncological applications of FDG PET imaging.

  Delbeke D. Delbeke D. J Nucl Med. 1999 Oct;40(10):1706-15. J Nucl Med. 1999. PMID: 10520713 Review. No abstract available.
• [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in cancer of the upper aerodigestive tract].

  Bourguet P; Groupe de Travail SOR. Bourguet P, et al. Bull Cancer. 2003 Feb;90 Spec No:S67-79. Bull Cancer. 2003. PMID: 12739338 Review. French. No abstract available.
• PET tracers for osteosarcoma.

  Reiman RE. Reiman RE. J Nucl Med. 2004 Aug;45(8):1424; author reply 1424-5. J Nucl Med. 2004. PMID: 15299071 No abstract available.